MicroRNA Profiles in Critically Ill Patients-Reference-Cited by-同舟云学术

MicroRNA Profiles in Critically Ill Patients

Published:2024-12 Issue:41 Volume:31 Page:6801-6825
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Alikiaii Babak¹,Bagherniya Mohammad²³,Askari Gholamreza²³,Rajendram Rajkumar⁴⁵,Sahebkar Amirhossein⁶⁷⁸

Affiliation:

1. Anesthesia and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2. Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3. Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

4. Department of Medicine, King Abdulaziz Medical City, King Abdulaziz International Medical Research Center, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia

5. College of Medicine, King Saud bin Abdulaziz University of Health Sciences, Riyadh, Saudi Arabia

6. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

7. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

8. Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

: The use of biomarkers to expedite diagnosis, prognostication, and treatment could significantly improve patient outcomes. The early diagnosis and treatment of critical illnesses can greatly reduce mortality and morbidity. Therefore, there is great interest in the discovery of biomarkers for critical illnesses. Micro-ribonucleic acids (miRNAs) are a highly conserved group of non-coding RNA molecules. They regulate the expression of genes involved in several developmental, physiological, and pathological processes. The characteristics of miRNAs suggest that they could be versatile biomarkers. Assay panels to measure the expression of several miRNAs could facilitate clinical decision-- making for a range of diseases. We have, in this paper, reviewed the current understanding of the role of miRNAs as biomarkers in critically ill patients.

Publisher

Bentham Science Publishers Ltd.

Reference292 articles.

1. Sakr Y.; Jaschinski U.; Wittebole X.; Szakmany T.; Lipman J.; Ñamendys-Silva S.A.; Martin-Loeches I.; Leone M.; Lupu M.N.; Vincent J.L.; Sepsis in intensive care unit patients: Worldwide data from the intensive care over nations audit. Open Forum Infect Dis 2018,5(12),ofy313

2. Honore P.M.; Jacobs R.; Hendrickx I.; De Waele E.; Van Gorp V.; Joannes-Boyau O.; De Regt J.; Boer W.; Spapen H.D.; Biomarkers in critical illness: Have we made progress? Int J Nephrol Renovasc Dis 2016,9,253-256

3. Heilmann E.; Gregoriano C.; Schuetz P.; Biomarkers of infection: Are they useful in the ICU? Semin Respir Crit Care Med 2019,40(4),465-475

4. Rello J; Blanch L; Preiser J-C; De Waele JJ; How to improve research on management of critically ill patients: Lessons learned from negative randomised clinical trials in the intensive care unit. Anaesth Crit Care Pain Med 2020,39(2),173-174

5. Ware L.B.; Biomarkers in critical illness: New insights and challenges for the future. Am J Respir Crit Care Med 2017,196(8),944-945